Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kinuko Mitani

Showing results (81-90 of 148) with videos related to

Pageof 15
Sort By:
Blood Advances|May 6, 2022
Incidence of acquired pure red cell aplasia: a nationwide epidemiologic analysis with 2 registry databases in JapanHideyuki Nakazawa, Kaoko Sakai, Akiko Ohta, et al.
Respiratory Medicine Case Reports|November 6, 2024
A case of pulmonary mucosa-associated lymphoid tissue lymphoma diagnosed by detecting t(11;18)(q21;q21) in bronchial lavage fluidYusuke Nakamura, Akihiro Takemasa, Yuki Ohoka, et al.
Leukemia & Lymphoma|September 21, 2010
Prognostic potential of detection of WT1 mRNA level in peripheral blood in adult acute myeloid leukemiaShuichi Miyawaki, Nahoko Hatsumi, Toshiharu Tamaki, et al.
Nature Medicine|February 18, 2004
AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesisMotoshi Ichikawa, Takashi Asai, Toshiki Saito, et al.
International Journal of Hematology|September 19, 2007
A prospective study of cyclosporine A treatment of patients with low-risk myelodysplastic syndrome: presence of CD55(-)CD59(-) blood cells predicts platelet responseTakayuki Ishikawa, Kaoru Tohyama, Shinji Nakao, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 1, 2020
[Effective treatment of POEMS syndrome accompanied by plasmacytoma with lenalidomide, dexamethasone, and local irradiation]Wataru Takahashi, Motoshi Ichikawa, Akihito Okazaki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 1, 2012
[CAG-GO therapy for patients with relapsed or primary refractory CD33-positive acute myelogenous leukemia]Wataru Takahashi, Yuko Nakamura, Jiro Tadokoro, et al.
International Journal of Hematology|October 7, 2005
Assessment of the international prognostic scoring system for determining chemotherapeutic indications in myelodysplastic syndrome: Japanese retrospective multicenter studyYoshikazu Ito, Kazuma Ohyashiki, Hisamaru Hirai, et al.
Leukemia Research Reports|April 4, 2022
Emergence of t(3;21)(q26.2;q22) during eltrombopag treatment in a patient with relapsed aplastic anemia who received chemotherapy for angioimmunoblastic T-cell lymphomaFumi Nakamura, Yuka Nakamura, Yasuhito Nannya, et al.
Blood|July 24, 2004
The transcriptionally active form of AML1 is required for hematopoietic rescue of the AML1-deficient embryonic para-aortic splanchnopleural (P-Sp) regionSusumu Goyama, Yuko Yamaguchi, Yoichi Imai, et al.
Pageof 15

Showing results (81-90 of 148) with videos related to

Sort By:
Pageof 15
Blood Advances|May 6, 2022
Incidence of acquired pure red cell aplasia: a nationwide epidemiologic analysis with 2 registry databases in JapanHideyuki Nakazawa, Kaoko Sakai, Akiko Ohta, et al.
Respiratory Medicine Case Reports|November 6, 2024
A case of pulmonary mucosa-associated lymphoid tissue lymphoma diagnosed by detecting t(11;18)(q21;q21) in bronchial lavage fluidYusuke Nakamura, Akihiro Takemasa, Yuki Ohoka, et al.
Leukemia & Lymphoma|September 21, 2010
Prognostic potential of detection of WT1 mRNA level in peripheral blood in adult acute myeloid leukemiaShuichi Miyawaki, Nahoko Hatsumi, Toshiharu Tamaki, et al.
Nature Medicine|February 18, 2004
AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesisMotoshi Ichikawa, Takashi Asai, Toshiki Saito, et al.
International Journal of Hematology|September 19, 2007
A prospective study of cyclosporine A treatment of patients with low-risk myelodysplastic syndrome: presence of CD55(-)CD59(-) blood cells predicts platelet responseTakayuki Ishikawa, Kaoru Tohyama, Shinji Nakao, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 1, 2020
[Effective treatment of POEMS syndrome accompanied by plasmacytoma with lenalidomide, dexamethasone, and local irradiation]Wataru Takahashi, Motoshi Ichikawa, Akihito Okazaki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 1, 2012
[CAG-GO therapy for patients with relapsed or primary refractory CD33-positive acute myelogenous leukemia]Wataru Takahashi, Yuko Nakamura, Jiro Tadokoro, et al.
International Journal of Hematology|October 7, 2005
Assessment of the international prognostic scoring system for determining chemotherapeutic indications in myelodysplastic syndrome: Japanese retrospective multicenter studyYoshikazu Ito, Kazuma Ohyashiki, Hisamaru Hirai, et al.
Leukemia Research Reports|April 4, 2022
Emergence of t(3;21)(q26.2;q22) during eltrombopag treatment in a patient with relapsed aplastic anemia who received chemotherapy for angioimmunoblastic T-cell lymphomaFumi Nakamura, Yuka Nakamura, Yasuhito Nannya, et al.
Blood|July 24, 2004
The transcriptionally active form of AML1 is required for hematopoietic rescue of the AML1-deficient embryonic para-aortic splanchnopleural (P-Sp) regionSusumu Goyama, Yuko Yamaguchi, Yoichi Imai, et al.
Pageof 15